The Department of Health and Human Services Monday began accepting orders from states and other jurisdictions for a portion of 442,000 additional doses of the JYNNEOS monkeypox vaccine. To stretch available doses up to five fold, the Food and Drug Administration last week issued an emergency use authorization allowing health care providers to administer the vaccine intradermally to adults. HHS previously allocated almost 1.1 million doses of the vaccine to jurisdictions, and expects the manufacturer to deliver another 5 million doses through next year. HHS Secretary Xavier Becerra this month declared the U.S. monkeypox outbreak, totaling almost 12,700 cases since May, a public health emergency.

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday recommended clinicians adhere to all recommendations to prevent monkeypox transmission in health care…
Headline
The Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center (HC3) yesterday alerted the sector to a monkeypox-themed phishing…
Headline
Only seven of 313 Colorado health care personnel exposed to monkeypox patients this May through July developed symptoms and none developed monkeypox during the…
Headline
The Los Angeles Department of Public Health, along with the Centers for Disease Control and Prevention, yesterday confirmed the first death due to monkeypox in…
Headline
Clinical data from patients treated under an investigational protocol for TPOXX (tecovirimat) support continuing to make the smallpox antiviral drug available…
Headline
The Food and Drug Administration yesterday issued the first emergency use authorization for a monkeypox diagnostic test, which is limited to laboratories…